Evidence map›Paper›PMID 31973118›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Titanium Dioxide Nanoparticles Alter the Cellular Phosphoproteome in A549 Cells.

Mathilde Biola-Clier, Jean-Charles Gaillard, Thierry Rabilloud, Jean Armengaud, Marie Carriere

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Safety Landscape of Therapeutic Nanozymes and Future Research Directions.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  3. Article
  4. Chronic effects of two rutile TiOParticle and fibre toxicology · 2022
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mathilde Biola-ClierUniv. Grenoble-Alpes, IRIG, SyMMES, CIBEST, F-38000 Grenoble, France.
Jean-Charles GaillardLaboratoire Innovations technologiques pour la Détection et le Diagnostic (Li2D), Service de Pharmacologie et Immunoanalyse (SPI), CEA, INRA, F-30207 Bagnols-sur-Cèze, France.
Thierry RabilloudChemistry and Biology of Metals, Univ. Grenoble Alpes, CNRS UMR5249, CEA, IRIG-DIESE-LCBM-ProMD, F-38054 Grenoble, France.
Jean ArmengaudLaboratoire Innovations technologiques pour la Détection et le Diagnostic (Li2D), Service de Pharmacologie et Immunoanalyse (SPI), CEA, INRA, F-30207 Bagnols-sur-Cèze, France.
Marie CarriereUniv. Grenoble-Alpes, IRIG, SyMMES, CIBEST, F-38000 Grenoble, France.
Commissariat à l'Énergie Atomique et aux Énergies Alternatives · FRInstitut de Recherche Interdisciplinaire de Grenoble · FRCentre National de la Recherche Scientifique · FR

Funding

Agence Nationale de la Recherche ANR-11-IDEX-0001-02Agence Nationale de la Recherche ANR-11-LABX-0064Commissariat à l'Énergie Atomique et aux Énergies Alternatives toxicology programmeFP7 320451
6 · The paper itself

Abstract

TiO

Indexed as

inhalationlungnanoparticleomicsphosphoproteomicsproteomicsTiO2

Identifiers

PMID31973118
PMCPMC7074930
OpenAlexW3002656882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.